ERBB2 c.3743A>T ;(p.Y1248F)

Variant ID: 17-37884272-A-T

NM_004448.2(ERBB2):c.3743A>T;(p.Y1248F)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology
Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C
Publication Date: 2021

Variant appearance in text: ERBB2: Y1248F
PubMed Link: 34630336
Variant Present in the following documents:
  • Table_1.xlsx, sheet 2
View BVdb publication page



Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.

Gastric Cancer : Official Journal Of The International Gastric Cancer Association And The Japanese Gastric Cancer Association
Hescheler, Daniel A DA; Plum, Patrick S PS; Zander, Thomas T; Quaas, Alexander A; Korenkov, Michael M; Gassa, Asmae A; Michel, Maximilian M; Bruns, Christiane J CJ; Alakus, Hakan H
Publication Date: 2020-07

Variant appearance in text: ERBB2: Y1248F
PubMed Link: 32107691
Variant Present in the following documents:
  • 10120_2020_1045_MOESM1_ESM.xlsx, sheet 12
View BVdb publication page



PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2.

Oncogene
Dong, H H; Ma, L L; Gan, J J; Lin, W W; Chen, C C; Yao, Z Z; Du, L L; Zheng, L L; Ke, C C; Huang, X X; Song, H H; Kumar, R R; Yeung, S C SC; Zhang, H H
Publication Date: 2017-01-19

Variant appearance in text: ERBB2: Y1248F
PubMed Link: 27345410
Variant Present in the following documents:
  • Main text
  • onc2016213a.pdf
View BVdb publication page